PURPOSE: We gained insights concerning outcomes associated with men who elect active surveillance for the management of localized prostate cancer. MATERIALS AND METHODS: This is a retrospective case series analysis of 40 patients diagnosed with localized prostate cancer since 1990 who elected active surveillance. RESULTS: A total of 31 patients remained on active surveillance for a median of 48 months (range 12 to 168). The 5-year probability of remaining on active surveillance was 74%. Most patients who abandoned this strategy did so within 33 months of diagnosis (range 12 to 84). An increasing prostate specific antigen and anxiety were the 2 most common reasons. A delay in treatment did not appear to compromise subsequent outcomes. CONCLUSIONS: Men with low grade prostate cancer can elect active surveillance and have excellent long-term results.
PURPOSE: We gained insights concerning outcomes associated with men who elect active surveillance for the management of localized prostate cancer. MATERIALS AND METHODS: This is a retrospective case series analysis of 40 patients diagnosed with localized prostate cancer since 1990 who elected active surveillance. RESULTS: A total of 31 patients remained on active surveillance for a median of 48 months (range 12 to 168). The 5-year probability of remaining on active surveillance was 74%. Most patients who abandoned this strategy did so within 33 months of diagnosis (range 12 to 84). An increasing prostate specific antigen and anxiety were the 2 most common reasons. A delay in treatment did not appear to compromise subsequent outcomes. CONCLUSIONS:Men with low grade prostate cancer can elect active surveillance and have excellent long-term results.
Authors: Baris Turkbey; Vijay P Shah; Yuxi Pang; Marcelino Bernardo; Sheng Xu; Jochen Kruecker; Julia Locklin; Angelo A Baccala; Ardeshir R Rastinehad; Maria J Merino; Joanna H Shih; Bradford J Wood; Peter A Pinto; Peter L Choyke Journal: Radiology Date: 2010-12-21 Impact factor: 11.105
Authors: Michael Koscuiszka; David Hatcher; Paul J Christos; Amy E Rose; Holly S Greenwald; Ya-lin Chiu; Samir S Taneja; Madhu Mazumdar; Peng Lee; Iman Osman Journal: Cancer Date: 2011-10-21 Impact factor: 6.860
Authors: Nora L Nock; Cathryn Bock; Christine Neslund-Dudas; Jennifer Beebe-Dimmer; Andrew Rundle; Deliang Tang; Michelle Jankowski; Benjamin A Rybicki Journal: Cancer Causes Control Date: 2009-12 Impact factor: 2.506
Authors: Lukasz Nyk; Tomasz Golabek; Jakub Dobruch; Michał Andrzej Skrzypczyk; Tomasz Dzik; Maciej Wysocki; Piotr L Chłosta; Andrzej Borówka Journal: Cent European J Urol Date: 2014-08-18